BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tan YW. Is dose modification or discontinuation of nilotinib necessary in nilotinib-induced hyperbilirubinemia? World J Meta-Anal 2021; 9(6): 488-495 [DOI: 10.13105/wjma.v9.i6.488]
URL: https://www.wjgnet.com/2308-3840/full/v9/i6/488.htm
Number Citing Articles
1
Biswajit Bhuyan, Somanath Padhi, Probodha Kumar Das, Chinmayee Panigrahi. Leukemia - From Biology to Clinic2023;  doi: 10.5772/intechopen.108334